Literature DB >> 25224765

Molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae from bloodstream infections and risk factors for mortality.

Stephan Gürntke1, Christian Kohler2, Ivo Steinmetz3, Yvonne Pfeifer4, Christoph Eller5, Petra Gastmeier6, Frank Schwab7, Rasmus Leistner8.   

Abstract

The prevalence of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae is growing worldwide. Infections with these bacteria are suspected to be related to increased mortality. We aimed to estimate the distribution of ESBL genotypes and to assess the impact on mortality associated with ESBL positivity in cases of bloodstream infection (BSI) due to K. pneumoniae. We performed a cohort study on patients with K. pneumoniae BSI between 2008 and 2011. Presence of ESBL genes was analyzed by PCR and sequencing. Risk factors for mortality were analyzed by Cox-proportional hazard regression. We identified 286 ESBL-negative (81%) and 66 (19%) ESBL-positive cases. 97% (n = 64) of the ESBL-positive isolates were susceptible for meropenem. The most common ESBL genotypes were CTX-M-15 (60%), SHV-5 (27%) and CTX-M-3 (5%). Significant risk factors for mortality were chronic pulmonary disease (HR 1.747) and moderate/severe renal disease (HR 2.572). ESBL positivity was not associated with increased mortality.
Copyright © 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bloodstream infection; ESBL; Klebsiella pneumoniae; Molecular epidemiology

Mesh:

Substances:

Year:  2014        PMID: 25224765     DOI: 10.1016/j.jiac.2014.08.012

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  11 in total

Review 1.  Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis.

Authors:  Weiping Ling; Luis Furuya-Kanamori; Yukiko Ezure; Patrick N A Harris; David L Paterson
Journal:  JAC Antimicrob Resist       Date:  2021-06-02

Review 2.  Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings.

Authors:  Edward Goldstein
Journal:  J Antimicrob Chemother       Date:  2021-10-11       Impact factor: 5.758

3.  Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity.

Authors:  Won-Hee Lee; Hyun-Il Choi; Sung-Wook Hong; Kwang-Sun Kim; Yong Song Gho; Seong Gyu Jeon
Journal:  Exp Mol Med       Date:  2015-09-11       Impact factor: 8.718

4.  Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study.

Authors:  Taro Noguchi; Yasufumi Matsumura; Masaki Yamamoto; Miki Nagao; Shunji Takakura; Satoshi Ichiyama
Journal:  BMC Infect Dis       Date:  2017-01-07       Impact factor: 3.090

5.  Estimating the burden of antimicrobial resistance: a systematic literature review.

Authors:  Nichola R Naylor; Rifat Atun; Nina Zhu; Kavian Kulasabanathan; Sachin Silva; Anuja Chatterjee; Gwenan M Knight; Julie V Robotham
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-25       Impact factor: 4.887

6.  Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).

Authors:  Lei Tian; Zhen Zhang; Ziyong Sun
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-28       Impact factor: 4.887

7.  Molecular Epidemiology of Extended-Spectrum Beta-Lactamase and AmpC Producing Enterobacteriaceae among Sepsis Patients in Ethiopia: A Prospective Multicenter Study.

Authors:  Melese Hailu Legese; Daniel Asrat; Abraham Aseffa; Badrul Hasan; Adane Mihret; Göte Swedberg
Journal:  Antibiotics (Basel)       Date:  2022-01-19

8.  Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.

Authors:  Christian Sakellariou; Stephan Gürntke; Ivo Steinmetz; Christian Kohler; Yvonne Pfeifer; Petra Gastmeier; Frank Schwab; Axel Kola; Maria Deja; Rasmus Leistner
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

9.  Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China.

Authors:  Lanyu Li; Huan Huang
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

10.  Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.

Authors:  Parichehr Shamsrizi; Beryl Primrose Gladstone; Elena Carrara; Dora Luise; Andrea Cona; Chiara Bovo; Evelina Tacconelli
Journal:  BMJ Open       Date:  2020-01-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.